AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 27736289 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic Stretching
Number of subjects: 30
Study 27736289 — intervention group
Group type: COMPARATOR
Intervention: Static Stretching
Number of subjects: 30
Study 27736289 — intervention group
Group type: COMPARATOR
Intervention: Control (Static Stretching)
Number of subjects: 30
Study 27736289 — intervention group
Group type: COMPARATOR
Intervention: Control (Dynamic Stretching)
Number of subjects: 30
Study 26102257 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-Body Vibration (WBV) training, twice a week for 8 months
Number of subjects: 37
Study 26102257 — intervention group
Group type: COMPARATOR
Intervention: Control group (no change in habitual lifestyle)
Number of subjects: 37
Study 26102257 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-Body Vibration (WBV) training
Number of subjects: 37
Study 24858163 — intervention group
Group type: EXPERIMENTAL
Intervention: Peginterferon α‐2a 180μg once weekly plus ribavirin daily for 24 weeks (genotypes 2 and 3) or 48 weeks (genotypes 1 and 4)
Number of subjects: 64
Study 24858163 — intervention group
Group type: EXPERIMENTAL
Intervention: Peginterferon α‐2a plus ribavirin
Number of subjects: 64
Study 23021898 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine patch
Number of subjects: 44
Study 23021898 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 23021898 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine challenge
Number of subjects: 44
Study 19641272 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole 15 mg once daily for 14 days
Number of subjects: 570
Study 19641272 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 570
Study 17584571 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stents
Number of subjects: 120
Study 17584571 — intervention group
Group type: COMPARATOR
Intervention: Bare-metal stents
Number of subjects: 120
Study 16280696 — intervention group
Group type: EXPERIMENTAL
Intervention: EPZ administered once daily
Number of subjects: 260
Study 16280696 — intervention group
Group type: COMPARATOR
Intervention: ABC + 3TC administered twice daily
Number of subjects: 260
Study 16280696 — intervention group
Group type: EXPERIMENTAL
Intervention: Both regimens
Number of subjects: 260
Study 11897728 — intervention group
Group type: COMPARATOR
Intervention: Usual-care counseling from a pharmacist
Number of subjects: 333
Study 11897728 — intervention group
Group type: EXPERIMENTAL
Intervention: Longer adherence counseling session and follow-up phone call from the pharmacist
Number of subjects: 333
Study 11897728 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Usual-care and Longer counseling)
Number of subjects: 333
Study 10534590 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous electrical nerve stimulation (PENS)
Number of subjects: 64
Study 10534590 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS)
Number of subjects: 64
Study 10534590 — intervention group
Group type: COMPARATOR
Intervention: Sham-PENS
Number of subjects: 64
Study 10534590 — intervention group
Group type: EXPERIMENTAL
Intervention: PENS
Number of subjects: 64
Study 10534590 — intervention group
Group type: EXPERIMENTAL
Intervention: TENS
Number of subjects: 64
Study 7785758 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron 4 mg
Number of subjects: 1044
Study 7785758 — intervention group
Group type: COMPARATOR
Intervention: Metoclopramide 10 mg
Number of subjects: 1044
Study 7785758 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1044
Study 2139338 — intervention group
Group type: EXPERIMENTAL
Intervention: GR32191B (80 mg; p.o.)
Number of subjects: 24
Study 2139338 — intervention group
Group type: EXPERIMENTAL
Intervention: GR32191B (40 mg; p.o.)
Number of subjects: 24
Study 2139338 — intervention group
Group type: COMPARATOR
Intervention: Glyceryl trinitrate (1 mg sub-lingually)
Number of subjects: 24
Study 2139338 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 369682 — intervention group
Group type: EXPERIMENTAL
Intervention: FAC (5‐fluorouracil, adriamycin, and cyclophosphamide)
Number of subjects: 166
Study 369682 — intervention group
Group type: EXPERIMENTAL
Intervention: FAI (5‐fluorouracil, adriamycin, and ifosfamide)
Number of subjects: 166
Study 30951686 — intervention group
Group type: EXPERIMENTAL
Intervention: Half-dose photodynamic therapy (PDT)
Number of subjects: 156
Study 30951686 — intervention group
Group type: COMPARATOR
Intervention: High-density subthreshold micropulse laser (HSML)
Number of subjects: 156
Study 28221062 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent Treatment of PTSD and Substance Use Disorders Using Prolonged Exposure
Number of subjects: 54
Study 24562315 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-Incision Transumbilical Surgery (SITUS)
Number of subjects: 63
Study 24562315 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional Laparoscopy (CLS)
Number of subjects: 63
Study 24562315 — intervention group
Group type: COMPARATOR
Intervention: Single-Port Laparoscopic Surgery (SPLS)
Number of subjects: 63
Study 23829679 — intervention group
Group type: EXPERIMENTAL
Intervention: Fragranced aerosol exposure (15 and 30 minutes)
Number of subjects: 0
Study 23829679 — intervention group
Group type: COMPARATOR
Intervention: Placebo aerosol exposure (15 and 30 minutes)
Number of subjects: 0
Study 21752262 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide (iNO) at 80 ppm
Number of subjects: 0
Study 21752262 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 19770281 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination treatment with S/pre‐S1/pre‐S2 vaccine and lamivudine
Number of subjects: 120
Study 19770281 — intervention group
Group type: COMPARATOR
Intervention: Lamivudine monotherapy
Number of subjects: 120
Study 19770281 — intervention group
Group type: COMPARATOR
Intervention: Vaccine monotherapy
Number of subjects: 120
Study 16714768 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary-artery catheter (PAC)
Number of subjects: 1000
Study 16714768 — intervention group
Group type: COMPARATOR
Intervention: Central venous catheter (CVC)
Number of subjects: 1000
Study 16714768 — intervention group
Group type: EXPERIMENTAL
Intervention: PAC
Number of subjects: 1000
Study 16714768 — intervention group
Group type: COMPARATOR
Intervention: CVC
Number of subjects: 1000
Study 15578399 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline 100 mg po b.i.d. for 30 days
Number of subjects: 146
Study 15578399 — intervention group
Group type: COMPARATOR
Intervention: Doxycycline 100 mg po b.i.d. for 45 days
Number of subjects: 146
Study 15578399 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline treatment for 45 days
Number of subjects: 146
Study 11149482 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength training (S)
Number of subjects: 126
Study 11149482 — intervention group
Group type: EXPERIMENTAL
Intervention: Fitness training (F)
Number of subjects: 126
Study 11149482 — intervention group
Group type: COMPARATOR
Intervention: Nonexercise control (C)
Number of subjects: 126
Study 9510680 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-stretch bandage (Setopress)
Number of subjects: 32
Study 9510680 — intervention group
Group type: COMPARATOR
Intervention: Short-stretch bandage (Elastocrepe)
Number of subjects: 32
Study 8044602 — intervention group
Group type: EXPERIMENTAL
Intervention: tranexamic acid 1 g three times daily
Number of subjects: 160
Study 8044602 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 160
Study 2508501 — intervention group
Group type: EXPERIMENTAL
Intervention: Metrifonate (MT, 10 mg/kg body weight)
Number of subjects: 312
Study 2508501 — intervention group
Group type: EXPERIMENTAL
Intervention: Praziquantel (PR, 40 mg/kg body weight)
Number of subjects: 312
Study 2508501 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 312
Study 1062357 — intervention group
Group type: EXPERIMENTAL
Intervention: Fructose (F)
Number of subjects: 125
Study 1062357 — intervention group
Group type: EXPERIMENTAL
Intervention: Xylitol (X)
Number of subjects: 125
Study 1062357 — intervention group
Group type: COMPARATOR
Intervention: Sucrose (S)
Number of subjects: 125
Study 1062357 — intervention group
Group type: EXPERIMENTAL
Intervention: Xylitol (X) in chewing gum
Number of subjects: 125
Study 1062357 — intervention group
Group type: COMPARATOR
Intervention: Sucrose (S) in chewing gum
Number of subjects: 125
Study 31273511 — intervention group
Group type: EXPERIMENTAL
Intervention: HAI raltitrexed (3 mg/m2 over 1 h) followed by oxaliplatin (130 mg/m2 over 2 h) every 3 weeks
Number of subjects: 57
Study 31273511 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 57
Study 27552929 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma of argon (G2)
Number of subjects: 30
Study 27552929 — intervention group
Group type: COMPARATOR
Intervention: Control group (G1)
Number of subjects: 30
Study 25499925 — intervention group
Group type: EXPERIMENTAL
Intervention: Zotarolimus-eluting stents (ZESs)
Number of subjects: 2332
Study 25499925 — intervention group
Group type: COMPARATOR
Intervention: Sirolimus-eluting stents (SESs)
Number of subjects: 2332
Study 22325728 — intervention group
Group type: EXPERIMENTAL
Intervention: Foam
Number of subjects: 30
Study 22325728 — intervention group
Group type: EXPERIMENTAL
Intervention: Gel
Number of subjects: 30
Study 22325728 — intervention group
Group type: EXPERIMENTAL
Intervention: Hand Wipe
Number of subjects: 30
Study 22325728 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated finger pads)
Number of subjects: 30
Study 21047395 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine (5 to 20 mg/day) for 24 to 28 weeks
Number of subjects: 980
Study 19281092 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium 18 microg once daily
Number of subjects: 234
Study 19281092 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 234
Study 16202527 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin A (25 units per trigger point)
Number of subjects: 18
Study 16202527 — intervention group
Group type: COMPARATOR
Intervention: Bupivacaine (0.5 ml of 0.5% per trigger point)
Number of subjects: 18
Study 12063948 — intervention group
Group type: EXPERIMENTAL
Intervention: Bipolar scissors (group BS)
Number of subjects: 53
Study 12063948 — intervention group
Group type: COMPARATOR
Intervention: Conventional method (group CM)
Number of subjects: 53
Study 10327086 — intervention group
Group type: EXPERIMENTAL
Intervention: Ergonomic modifications to tasks
Number of subjects: 20
Study 10327086 — intervention group
Group type: COMPARATOR
Intervention: Before ergonomic modifications
Number of subjects: 20
Study 10327086 — intervention group
Group type: EXPERIMENTAL
Intervention: After ergonomic modifications
Number of subjects: 20
Study 1723323 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg propranolol
Number of subjects: 31
Study 1723323 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 6280600 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefotaxime (1-g dose)
Number of subjects: 39
Study 6280600 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefotaxime
Number of subjects: 39
Study 31326438 — intervention group
Group type: EXPERIMENTAL
Intervention: Hungry group detecting high-fat food
Number of subjects: 0
Study 31326438 — intervention group
Group type: COMPARATOR
Intervention: Satiated group detecting high-fat food
Number of subjects: 0
Study 31326438 — intervention group
Group type: EXPERIMENTAL
Intervention: Hungry group detecting food targets
Number of subjects: 0
Study 31326438 — intervention group
Group type: COMPARATOR
Intervention: Satiated group detecting food targets
Number of subjects: 0
Study 28186251 — intervention group
Group type: EXPERIMENTAL
Intervention: elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate (single-tablet regimen)
Number of subjects: 151
Study 25658240 — intervention group
Group type: EXPERIMENTAL
Intervention: Black tea (129 mg flavonoids)
Number of subjects: 19
Study 25658240 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 25799800 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical steroid (Mometasone furoate 0.1% cream) and Topical placental extract gel
Number of subjects: 100
Study 25799800 — intervention group
Group type: COMPARATOR
Intervention: Topical steroid (Mometasone furoate 0.1% cream) and Topical Tacrolimus 0.1% cream
Number of subjects: 100
Study 22736463 — intervention group
Group type: EXPERIMENTAL
Intervention: Supersaturated calcium phosphate rinse (SCPR) four times daily
Number of subjects: 40
Study 22736463 — intervention group
Group type: COMPARATOR
Intervention: Customary care (topical mouth solutions made with salvia leaf extract, iodine-povidine, and fluconazole)
Number of subjects: 40
Study 17559743 — intervention group
Group type: EXPERIMENTAL
Intervention: Olopatadine 0.2%
Number of subjects: 92
Study 17559743 — intervention group
Group type: COMPARATOR
Intervention: Epinastine 0.05%
Number of subjects: 92
Study 17006401 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose oral contraceptive (LD-OC) pill
Number of subjects: 917
Study 17006401 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 917
Study 12813191 — intervention group
Group type: EXPERIMENTAL
Intervention: Planar scintigraphy (20% threshold) in 51 patients
Number of subjects: 91
Study 12813191 — intervention group
Group type: EXPERIMENTAL
Intervention: SPECT (30% and 35% threshold) in 40 patients
Number of subjects: 91
Study 12813191 — intervention group
Group type: COMPARATOR
Intervention: Ultrasonography
Number of subjects: 91
Study 11112975 — intervention group
Group type: EXPERIMENTAL
Intervention: Cochlear Implant (CI) users
Number of subjects: 91
Study 11112975 — intervention group
Group type: COMPARATOR
Intervention: Control group (deaf candidates on the waiting list for CIs)
Number of subjects: 91
Study 11112975 — intervention group
Group type: EXPERIMENTAL
Intervention: Nijmegen Cochlear Implantation Questionnaire (NCIQ)
Number of subjects: 91
Study 8806347 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Density Lipoprotein Intervention
Number of subjects: 2531
Study 1320440 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone
Number of subjects: 19
Study 1320440 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 6370980 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomifensine
Number of subjects: 63
Study 6370980 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 63
Study 6370980 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study 31790749 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasted-refed group (fasted for 30 days and then fed to satiation for 30 days)
Number of subjects: 120
Study 31790749 — intervention group
Group type: COMPARATOR
Intervention: Control group (fed until satiation for 60 days)
Number of subjects: 120
Study 31790749 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasted-refed group
Number of subjects: 120
Study 30569640 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent fasting at 70% energy requirements (IF70)
Number of subjects: 88
Study 30569640 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent fasting at 100% energy requirements (IF100)
Number of subjects: 88
Study 30569640 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 88
Study 30569640 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary restriction at 70% energy requirements (DR70)
Number of subjects: 88
Study 27765481 — intervention group
Group type: EXPERIMENTAL
Intervention: HEART Pathway protocol
Number of subjects: 270
Study 27765481 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 270
Study 25592055 — intervention group
Group type: EXPERIMENTAL
Intervention: Developmentally Appropriate Symbols (DAS)
Number of subjects: 40
Study 25592055 — intervention group
Group type: COMPARATOR
Intervention: Picture Communication Symbols (PCS)
Number of subjects: 40
Study 23030240 — intervention group
Group type: EXPERIMENTAL
Intervention: Enamel matrix derivative (EMD) with simplified papilla preservation flap (SPPF) technique
Number of subjects: 50
Study 23030240 — intervention group
Group type: COMPARATOR
Intervention: Simplified papilla preservation flap (SPPF) alone
Number of subjects: 50
Study 21453656 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide-soaked Merocel MMS
Number of subjects: 48
Study 21453656 — intervention group
Group type: EXPERIMENTAL
Intervention: Manuka honey-soaked Merocel MMS
Number of subjects: 48
Study 21453656 — intervention group
Group type: COMPARATOR
Intervention: Nonmedicated Merocel MMS
Number of subjects: 48
Study 19168520 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based walking and resistance exercise programme plus specialist nurse care
Number of subjects: 169
Study 19168520 — intervention group
Group type: COMPARATOR
Intervention: Specialist nurse care alone
Number of subjects: 169
Study 16460491 — intervention group
Group type: EXPERIMENTAL
Intervention: Terlipressin
Number of subjects: 40
Study 16460491 — intervention group
Group type: COMPARATOR
Intervention: Albumin
Number of subjects: 40
Study 15011975 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooperative Learning (CL) activities
Number of subjects: 22
Study 15011975 — intervention group
Group type: COMPARATOR
Intervention: Lecture
Number of subjects: 22
Study 11354851 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative brace for 6 weeks
Number of subjects: 62
Study 11354851 — intervention group
Group type: COMPARATOR
Intervention: Nonbraced rehabilitation for 6 weeks
Number of subjects: 62
Study 9207371 — intervention group
Group type: EXPERIMENTAL
Intervention: Itraconazole oral solution (100-200 mg once daily for 3-8 weeks)
Number of subjects: 126
Study 9207371 — intervention group
Group type: COMPARATOR
Intervention: Fluconazole tablets (100-200 mg once daily for 3-8 weeks)
Number of subjects: 126
Study 7584265 — intervention group
Group type: EXPERIMENTAL
Intervention: Field perspective
Number of subjects: 0
Study 7584265 — intervention group
Group type: EXPERIMENTAL
Intervention: Observer perspective
Number of subjects: 0
Study 2950303 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular vaccine (20 micrograms)
Number of subjects: 40
Study 2950303 — intervention group
Group type: COMPARATOR
Intervention: Intradermal vaccine (2 micrograms)
Number of subjects: 40
Study 2950303 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study 30040009 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio taping (KT)
Number of subjects: 54
Study 30040009 — intervention group
Group type: COMPARATOR
Intervention: Placebo Kinesio taping (placebo KT)
Number of subjects: 54
Study 28476039 — intervention group
Group type: EXPERIMENTAL
Intervention: Nano-pulse stimulation (NPS) treatment
Number of subjects: 24
Study 28476039 — intervention group
Group type: COMPARATOR
Intervention: Control (surgery or no treatment)
Number of subjects: 24
Study 25911162 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy sleep (10 hours in bed)
Number of subjects: 67
Study 25911162 — intervention group
Group type: COMPARATOR
Intervention: Sleep restriction (6.5 hours in bed)
Number of subjects: 67
Study 23262114 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated e-mails promoting evidence-based self-help strategies
Number of subjects: 568
Study 23262114 — intervention group
Group type: COMPARATOR
Intervention: E-mails providing non-directive depression information (Control)
Number of subjects: 568
Study 21491356 — intervention group
Group type: EXPERIMENTAL
Intervention: Expiratory muscle strength training
Number of subjects: 0
Study 21491356 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory muscle strength training
Number of subjects: 0
Study 19218826 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic cranial irradiation (PCI)
Number of subjects: 0
Study 16863044 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week, home-based, low- to moderate-intensity combined walking and education program
Number of subjects: 0
Study 16863044 — intervention group
Group type: COMPARATOR
Intervention: Education alone (control)
Number of subjects: 0
Study 12514443 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-delivered partner treatment with azithromycin (dose not specified)
Number of subjects: 1787
Study 12514443 — intervention group
Group type: COMPARATOR
Intervention: Self-referral (control group)
Number of subjects: 1787
Study 14675583 — intervention group
Group type: EXPERIMENTAL
Intervention: Transient no-reflow during primary percutaneous coronary intervention
Number of subjects: 1192
Study 14675583 — intervention group
Group type: COMPARATOR
Intervention: No transient no-reflow during primary percutaneous coronary intervention
Number of subjects: 1192
Study 11016339 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduction pneumoplasty (RP)
Number of subjects: 60
Study 11016339 — intervention group
Group type: COMPARATOR
Intervention: Comprehensive respiratory rehabilitation (RR)
Number of subjects: 60
Study 8851740 — intervention group
Group type: EXPERIMENTAL
Intervention: Manipulated evaluation apprehension
Number of subjects: 0
Study 8851740 — intervention group
Group type: EXPERIMENTAL
Intervention: Manipulated self‐consciousness
Number of subjects: 0
Study 8851740 — intervention group
Group type: COMPARATOR
Intervention: Alcohol consumption
Number of subjects: 0
Study 8851740 — intervention group
Group type: EXPERIMENTAL
Intervention: Broca's aphasics
Number of subjects: 0
Study 8851740 — intervention group
Group type: EXPERIMENTAL
Intervention: Wernicke's aphasics
Number of subjects: 0
Study 1847363 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole liver irradiation (33 Gy)
Number of subjects: 33
Study 1847363 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole liver irradiation (30 Gy) plus a boost of 15 Gy (6 patients) or 30 Gy (7 patients)
Number of subjects: 33
Study 1847363 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent use of intraarterial hepatic 5-fluorodeoxyuridine (FdUrd) as a radiosensitizer
Number of subjects: 33
Study 1847363 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperfractionation (1.5 Gy fractions given bid greater than 4 hr apart)
Number of subjects: 33
Study 30848259 — intervention group
Group type: EXPERIMENTAL
Intervention: SPI‐7 (172 kcal sugar beverage with SPI at pH 7)
Number of subjects: 12
Study 30848259 — intervention group
Group type: EXPERIMENTAL
Intervention: SPI‐6 (172 kcal sugar beverage with SPI at pH 6)
Number of subjects: 12
Study 30848259 — intervention group
Group type: EXPERIMENTAL
Intervention: SPI + ALG‐7 (172 kcal sugar beverage with mixed SPI and alginate at pH 7)
Number of subjects: 12